Aviva’s Amgen AMGN Stock Holding History

Aviva’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$163M	Buy	464,183 +13,282	+3%	+$4.73M	0.27%	67
2025 Q4	$148M	Buy	450,901 +23,465	+5%	+$7.44M	0.25%	75
2025 Q3	$121M	Buy	427,436 +25,530	+6%	+$7.4M	0.22%	90
2025 Q2	$112M	Buy	401,906 +26,292	+7%	+$7.45M	0.23%	91
2025 Q1	$117M	Buy	375,614 +51,890	+16%	+$15.3M	0.28%	69
2024 Q4	$84.4M	Sell	323,724 -9,856	-3%	-$2.92M	0.22%	98
2024 Q3	$107M	Buy	333,580 +7,809	+2%	+$2.55M	0.28%	70
2024 Q2	$102M	Buy	325,771 +70,311	+28%	+$20.7M	0.28%	66
2024 Q1	$72.6M	Buy	255,460 +11,503	+5%	+$3.37M	0.24%	80
2023 Q4	$70.3M	Buy	243,957 +39,486	+19%	+$10.8M	0.25%	77
2023 Q3	$55M	Buy	204,471 +6,960	+4%	+$1.74M	0.23%	76
2023 Q2	$43.9M	Buy	197,511 +46,084	+30%	+$10.7M	0.18%	106
2023 Q1	$36.6M	Sell	151,427 -31,917	-17%	-$7.83M	0.17%	150
2022 Q4	$48.2M	Buy	183,344 +25,344	+16%	+$6.79M	0.24%	85
2022 Q3	$35.6M	Sell	158,000 -35,273	-18%	-$8.55M	0.21%	100
2022 Q2	$47M	Buy	193,273 +15,208	+9%	+$3.73M	0.25%	74
2022 Q1	$43.1M	Sell	178,065 -6,026	-3%	-$1.38M	0.22%	86
2021 Q4	$41.4M	Buy	184,091 +8,596	+5%	+$1.81M	0.17%	124
2021 Q3	$37.3M	Sell	175,495 -23,391	-12%	-$5.38M	0.17%	133
2021 Q2	$48.5M	Sell	198,886 -10,296	-5%	-$2.53M	0.21%	102
2021 Q1	$52M	Sell	209,182 -1,498	-0.7%	-$357K	0.25%	88
2020 Q4	$48.4M	Buy	210,680 +4,465	+2%	+$1.03M	0.25%	87
2020 Q3	$52.4M	Sell	206,215 -7,968	-4%	-$1.97M	0.31%	78
2020 Q2	$50.5M	Sell	214,183 -8,525	-4%	-$1.95M	0.31%	79
2020 Q1	$45.1M	Buy	222,708 +10,321	+5%	+$2.25M	0.33%	67
2019 Q4	$51.2M	Sell	212,387 -4,725	-2%	-$1.04M	0.31%	73
2019 Q3	$42M	Sell	217,112 -9,149	-4%	-$1.76M	0.28%	84
2019 Q2	$41.7M	Sell	226,261 -58,110	-20%	-$10.4M	0.29%	79
2019 Q1	$54M	Sell	284,371 -54,389	-16%	-$10.4M	0.36%	68
2018 Q4	$65.9M	Sell	338,760 -77,808	-19%	-$15.2M	0.49%	49
2018 Q3	$86.3M	Sell	416,568 -21,567	-5%	-$4.25M	0.47%	49
2018 Q2	$80.9M	Sell	438,135 -35,863	-8%	-$6.34M	0.48%	44
2018 Q1	$80.8M	Sell	473,998 -68,255	-13%	-$12.5M	0.49%	47
2017 Q4	$94.3M	Sell	542,253 -62,608	-10%	-$11.1M	0.53%	44
2017 Q3	$113M	Buy	604,861 +711	+0.1%	+$126K	0.61%	38
2017 Q2	$104M	Sell	604,150 -44,245	-7%	-$7.2M	0.58%	37
2017 Q1	$106M	Sell	648,395 -29,431	-4%	-$4.89M	0.61%	34
2016 Q4	$99.1M	Sell	677,826 -4,451	-0.7%	-$670K	0.59%	36
2016 Q3	$114M	Buy	682,277 +39,143	+6%	+$6.62M	0.71%	27
2016 Q2	$97.9M	Buy	643,134 +51,353	+9%	+$7.98M	0.67%	29
2016 Q1	$88.7M	Sell	591,781 -4,933	-0.8%	-$733K	0.66%	30
2015 Q4	$96.9M	Buy	596,714 +11,637	+2%	+$1.83M	0.73%	28
2015 Q3	$80.9M	Sell	585,077 -133,202	-19%	-$21M	0.67%	29
2015 Q2	$110M	Sell	718,279 -45,337	-6%	-$7.26M	0.78%	19
2015 Q1	$122M	Buy	763,616 +65,720	+9%	+$10.4M	0.84%	15
2014 Q4	$111M	Sell	697,896 -93,144	-12%	-$14.5M	0.86%	14
2014 Q3	$111M	Sell	791,040 -11,919	-1%	-$1.56M	0.88%	17
2014 Q2	$95M	Buy	802,959 +72,696	+10%	+$8.42M	0.73%	21
2014 Q1	$90.1M	Sell	730,263 -40,067	-5%	-$4.86M	0.73%	20
2013 Q4	$87.9M	Sell	770,330 -14,351	-2%	-$1.63M	0.74%	21
2013 Q3	$87.8M	Buy	784,681 +48,823	+7%	+$5.29M	0.77%	22
2013 Q2	$72.6M	Buy	+735,858	New	+$76.4M	0.73%	24

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Aviva's AMGN Position: Q1 2026 in Review

Aviva increased its Amgen (AMGN) stake by 2.9% in Q1 2026, buying an estimated $4.73M and bringing the position to 464,183 shares worth $163M. The position accounts for 0.27% of the portfolio, ranked #67.

Aviva first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Aviva held 464,183 shares of Amgen worth $163M as of Q1 2026.
Aviva bought 13,282 Amgen shares in Q1 2026, an estimated $4.73M.
Amgen made up 0.27% of Aviva's portfolio in Q1 2026, its #67 holding.
Aviva first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.